5-Aminosalicylate

Known as: 5 Aminosalicylate, 5 aminosalicylates 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
OBJECTIVES:We aimed to determine if use of 5-aminosalicylates (5-ASA) was associated with a reduced risk of colorectal cancer… (More)
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
Is this relevant?
2008
2008
AIM To investigate the therapeutic effects of the combined use of rosiglitazone and aminosalicylate on mild or moderately active… (More)
Is this relevant?
2006
2006
It is generally accepted that 5-aminosalicylate (5-ASA; mesalamine), widely used in inflammatory bowel disease therapy, exerts… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2005
Review
2005
BACKGROUND AND AIMS The objective of this study was to evaluate the risk of colorectal cancer (CRC) in patients taking… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2005
2005
AIM To study 5-aminosalicylate nephrotoxicity in patients with inflammatory bowel disease in the UK. METHODS A detailed postal… (More)
Is this relevant?
2001
2001
OBJECTIVES To assess the effect of 5-aminosalicylate treatment in conjunction with azathioprine on remission maintenance in… (More)
Is this relevant?
1999
1999
The purpose of this study was to determine the characteristics of intestinal absorption and metabolism of 5-aminosalicylic acid… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The action of the phenolic compounds acetaminophen, salicylate, and 5-aminosalicylate (5-ASA) as inhibitors of lipid peroxidation… (More)
Is this relevant?
1990
1990
The bioavailability of three pure 5-aminosalicylic (5-ASA) preparations (Asacol, Claversal, and Pentasa) was studied in 8… (More)
Is this relevant?
1987
1987
It has been postulated that oxygen radicals may play a role in the pathogenesis of inflammatory bowel disease. If so, then a drug… (More)
Is this relevant?